Here's Why You Should Retain Myriad Genetics (MYGN) for Now

Published on October 4, 2021

Investors are optimistic about Myriad Genetics (MYGN) owing to strong testing volume growth and notable product launches.

Continue reading on website
Other news

Weyerhaeuser (WY) Stock Moves -0.14%: What You Should Know

October 4, 2021
Weyerhaeuser (WY) closed the most recent trading day at $35.72, moving -0.14% from the previous trading session.

There will be a shortage of Xbox consoles until 2022 as confirmed by Phil Spencer, director of the company owned by Microsoft

October 4, 2021
Bad news for gamers. The lack of chips that has the entire technology industry in check, will cause the shortage of Xbox consoles to last until 2022.